We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

108 hedge funds and large institutions have $95.6M invested in Praxis Precision Medicines in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 13

14% more funds holding

Funds holding: 95 → 108 (+13)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.15% less ownership

Funds ownership: 6.32% → 6.16% (-0.15%)

6% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 31

9% less capital invested

Capital invested by funds: $106M → $95.6M (-$9.9M)

Holders
108
Holders Change
+13
Holders Change %
+13.68%
% of All Funds
1.86%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
29
Reduced
31
Closed
13
Calls
$541K
Puts
–
Net Calls
+$541K
Net Calls Change
-$536K

Top Buyers

1
EC
EcoR1 Capital
California
+$4.27M
2
Millennium Management
Millennium Management
New York
+$2.34M
3
Goldman Sachs
Goldman Sachs
New York
+$1.75M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.66M
5
GCM
Graham Capital Management
Connecticut
+$1.38M

Top Sellers

1
State Street
State Street
Massachusetts
-$14M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$2.45M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.19M
4
LCM
Laurion Capital Management
New York
-$959K
5
Bank of America
Bank of America
North Carolina
-$925K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
101
Royal Bank of Canada
Ontario, Canada
$1K +$1.15K +23 +164%
PA
102
Parallel Advisors
California
$1K +$1.25K +25 New
CUAMC
103
China Universal Asset Management Company
China
$1K +$1.4K +28 New
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
$31 +$39.9K +800 New
WP
105
Woodline Partners
California
– -$756K -20,583 Closed
Rafferty Asset Management
106
Rafferty Asset Management
New York
– -$563K -15,323 Closed
UBS Group
107
UBS Group
Switzerland
– -$384K -10,447 Closed
ECM
108
Endurant Capital Management
California
– -$194K -5,273 Closed
PI
109
PEAK6 Investments
Illinois
– -$85.6K -4,965 Closed
EFM
110
E Fund Management
China
– -$64K -1,738 Closed
QT
111
Quantbot Technologies
New York
– -$51K -1,403 Closed
Wells Fargo
112
Wells Fargo
California
– -$9.32K -187 -95%
CAPTRUST Financial Advisors
113
CAPTRUST Financial Advisors
North Carolina
– -$3K -90 Closed
Nisa Investment Advisors
114
Nisa Investment Advisors
Missouri
– -$1K -37 Closed
QCG
115
Quadrant Capital Group
Ohio
– -$1K -27 Closed
S
116
SignatureFD
Georgia
– -$1K -14 Closed
US Bancorp
117
US Bancorp
Minnesota
– -$1K -14 Closed
Osaic Holdings
118
Osaic Holdings
Arizona
– +$598 +12 New
1 2 3 4
5

PRAX Hedge Fund Activity: Q3 2022 in Review

108 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q3 2022, worth a combined $95.6M — down 9.4% from $106M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PRAX positions and 13 closed out — a net gain of 13 holders — while 29 added to existing stakes and 31 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $4.27M. The largest seller was State Street, cutting an estimated $14M.

  • 108 institutional investors held Praxis Precision Medicines (PRAX) as of Q3 2022, up from 95 in Q2 2022.
  • Funds reported $95.6M of Praxis Precision Medicines stock for Q3 2022, down 9.4% quarter-over-quarter.
  • 26 funds opened new Praxis Precision Medicines positions in Q3 2022 and 13 closed out, a net change of +13 holders.
  • The largest Praxis Precision Medicines buyer in Q3 2022 was EcoR1 Capital, an estimated $4.27M added.
  • The largest Praxis Precision Medicines seller in Q3 2022 was State Street, an estimated $14M sold.

Based on aggregated 13F filings for Q3 2022.